By KATIE THOMAS
Filings in a case against Bayer and Johnson & Johnson over the blood-thinning drug Xarelto said the companies helped mislead editors at The New England Journal of Medicine.
Published: March 2, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1SgGNq6
from WordPress http://ift.tt/1L4bflU
via Hadi Aboukhater
No comments:
Post a Comment